Abstract:As one of the most important organelles in most eukaryotic cells,mitochondria not only supply cellular energy,but also involve in a range of other processes,such as cellular differentiation,cell death,as well as the control of the cell cycle and cell growth.Besides,cancer cell mitochondria exhibit an extensive metabolic activity and are more susceptible to mitochondrial perturbation than normal cell mitochondria.Consequently,induction of apoptosis through targeting of mitochondria of cancer cells can be an effective therapy strategy.Here,we conducted a hierarchical targeted delivery system that could deliver the chemotherapeutic agents,resveratrol (1),sequentially to tumor cells and mitochondria.In detail,the mitochondrial targeting prodrug triphenylphosphine-resveratrol (TPP-1) was constructed by conjugation.Then,the TPP-1 was entrapped in the lipid bilayer of liposomes.Followed,the liposomes were decorated with polyethylene glycol (PEG) and the cell targeting peptide RGD to form the hierarchical targeted delivery system (RLP-TPP-1 liposomes).The prepared RLP-TPP-1 liposomes were regularly spherical and well-distributed,the average particle size,ζ potential and encapsulation efficiency were (128.1±3.4) nm,(-20.28± 1.68) mV and (75.6±0.8) ％,respectively.The results of in vitro cytotoxicity test showed that the blank liposomes were nontoxic against MDA-MB-231 cells overexpressing αvβ3 receptors.However,the drug-loaded liposomes presented a significant inhibitory effect on MDA-MB-231 cells in a dose-dependent manner.In addition,the IC50 value (4.95 μmol/L) of the RLP-TPP-1 liposomes was the lowest among the tested liposomes.Cellular uptake experiment revealed that the uptake of RGD decorated liposomes were significantly higher than that of the undecorated liposomes.The results of JC-1 staining test showed that the RLP-TPP-1 liposomes performed the best mitochondrial targeting effect and increased apoptosis distinctively.In summary,RLP-TPP-1 liposomes could target to tumor cells and deliver 1 to mitochondria,resulting in the mitochondrial dysfunction and apoptosis of cancer cells.

Preparation of RGD-modified long circulating liposome loading matrine, and its in vitro anti-cancer effects

Preparation Of Rgd-Modified Long Circulating Liposome Loading Matrine, And Its In Vitro Anti-Cancer Effects

Preparation of RGD Peptide/Folate Acid Double-Targeted Mesoporous Silica Nanoparticles and Its Application in Human Breast Cancer MCF-7 Cells

RGD-targeted Paramagnetic Liposomes for Early Detection of Tumor: in Vitro and in Vivo Studies.

Preparation and Multidrug Resistance Reversal Study of Matrine-Loaded Solid Lipid Nanoparticles

RGD-modified Liposomes Enhance Efficiency of Aclacinomycin A Delivery: Evaluation of Their Effect in Lung Cancer.

Preparation and Preliminary in vitro Evaluation of RGD Modified Mitochondrial Targeting Long-circulating Liposomes

The research of RGD-conjugated PLA-PLL nanoparticles carriers on targeted delivery to tumor

[Preparation of Doxorubicin-Loaded Stealth Liposomes Modified with RGD Mimetic and Cellular Association in Vitro].

Anti-tumor Efficiency of NGR-modified PEG-PLGA Micelles Containing Paclitaxel: in Vitro and in Vivo

Novel RGD-decorated micelles loaded with doxorubicin for targeted breast cancer chemotherapy

Liposomes Co-Modified with Cholesterol Anchored Cleavable PEG and Octaarginines for Tumor Targeted Drug Delivery

RGD-modified Ph-Sensitive Liposomes for Docetaxel Tumor Targeting.

RGD and cell penetrating peptides co-modiifed paclitaxel loaded liposome inhibit the A549 cells

Enhanced Anticancer Efficacy of Paclitaxel Through Multistage Tumor-Targeting Liposomes Modified with RGD and KLA Peptides

Discovery And In Vivo Evaluation Of Novel Rgd-Modified Lipid-Polymer Hybrid Nanoparticles For Targeted Drug Delivery

RGD(Arg-Gly-Asp) Internalized Docetaxel-Loaded Ph Sensitive Liposomes: Preparation, Characterization and Antitumor Efficacy in Vivo and in Vitro.

Preparation and evaluation of the anti-cancer properties of RGD-modified curcumin-loaded chitosan/perfluorohexane nanocapsules in vitro

A CD326 monoclonal antibody modified core cross-linked curcumin-polyphosphoester prodrug for targeted delivery and cancer treatment

Rg3-lipo biomimetic delivery of paclitaxel enhances targeting of tumors and myeloid-derived suppressor cells

In Vivo Biodistribution and Anti-Tumor Efficacy Evaluation of Doxorubicin and Paclitaxel-Loaded Pluronic Micelles Decorated with c(RGDyK) Peptide